Cargando…

COVID‐19 and venous thromboembolism: A narrative review

COVID‐19 (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) is associated with coagulopathy through numerous mechanisms. The reported incidence of venous thromboembolism (VTE) in hospitalized patients with COVID‐19 has varied widely, and several meta‐analyses have been performed to asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelini, Dana E., Kaatz, Scott, Rosovsky, Rachel P., Zon, Rebecca L., Pillai, Shreejith, Robertson, William E., Elavalakanar, Pavania, Patell, Rushad, Khorana, Alok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847419/ https://www.ncbi.nlm.nih.gov/pubmed/35224417 http://dx.doi.org/10.1002/rth2.12666

Ejemplares similares

Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices
por: Lam, Barbara D., et al.
Publicado: (2023)

Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors
por: Miller, Eric J., et al.
Publicado: (2022)

Predicting outcomes in patients with cancer and atrial fibrillation
por: Gutierrez, Alejandra, et al.
Publicado: (2019)

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

Evolving Treatment Options for Cancer-Related Venous Thromboembolism
por: Attia, Doaa, et al.
Publicado: (2020)

RNA expression and risk of venous thromboembolism in lung cancer
por: Sussman, Tamara A., et al.
Publicado: (2019)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)

Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016)

Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study
por: Khan, Adeel M., et al.
Publicado: (2022)

Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
por: Witt, Daniel M., et al.
Publicado: (2016)

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer
por: Chaturvedi, Shruti, et al.
Publicado: (2014)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
por: Delluc, Aurélien, et al.
Publicado: (2020)

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
por: Streiff, Michael B., et al.
Publicado: (2018)

Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations
por: Moyer, Genevieve Claire, et al.
Publicado: (2018)

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
por: Khorana, Alok A, et al.
Publicado: (2013)

Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
por: Khorana, Alok A., et al.
Publicado: (2022)

Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19
por: Vaughn, Valerie M., et al.
Publicado: (2021)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
por: Thondapu, Vikas, et al.
Publicado: (2021)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
por: Groat, Danielle, et al.
Publicado: (2022)

Deep vein thrombosis protocol optimization to minimize healthcare worker exposure in coronavirus disease-2019
por: Dua, Anahita, et al.
Publicado: (2021)

The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
por: Hsu, Charles, et al.
Publicado: (2022)

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
por: Lee, Agnes YY, et al.
Publicado: (2013)

Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review
por: Blondon, Marc, et al.
Publicado: (2022)

Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
por: Khorana, Alok A, et al.
Publicado: (2023)

Post-infectious headache: a reactive headache?
por: Prakash, Sanjay, et al.
Publicado: (2011)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
por: Rossel, Anne, et al.
Publicado: (2020)

Eligibility for Posthospitalization Venous Thromboembolism Prophylaxis in Hospitalized Patients With COVID‐19: A Retrospective Cohort Study
por: Vaughn, Valerie M., et al.
Publicado: (2022)

All-Cause and Potentially Disease-Related Health Care Costs Associated with Venous Thromboembolism in Commercial, Medicare, and Medicaid Beneficiaries
por: Lefebvre, Patrick, et al.
Publicado: (2012)

Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review
por: Galeano-Valle, Francisco, et al.
Publicado: (2021)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Acute infections and venous thromboembolism
por: Schmidt, M, et al.
Publicado: (2012)

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2017)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
por: Joyce, Elizabeth, et al.
Publicado: (2022)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j9a1dvc6q85nqv43d1thirk769